FOI request 1221 – Special arrangement for Opiate dependence treatment program
The information released on this page relates to the supply of pharmaceutical benefits for the purpose of treating opiate dependence
Special arrangement for Opiate Dependence Treatment Program
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
This request looks at the special arrangements in which the Australian Government funds the cost of buprenorphine, buprenorphine with naloxone and methadone supplied as pharmaceutical benefits through clinics and pharmacies approved by state and territory governments.